Literature DB >> 18083930

The role of NFAT in osteoclast formation.

Hiroshi Takayanagi1.   

Abstract

Osteoclasts are cells of monocyte-macrophage origin that degrade bone matrix. Receptor activator of NF-kappaB ligand (RANKL) induces osteoclast formation in the presence of macrophage-colony-stimulating factor (M-CSF) and costimulatory signals. RANKL induces activation of the TNF receptor-associated factor 6 (TRAF6) and c-Fos pathways, which lead to the osteoclast-specific event, that is, autoamplification of nuclear factor of activated T cells (NFAT)c1, the master transcription factor for osteoclast differentiation. Autoamplification of NFATc1 is dependent on the calcium signaling of immunoglobulin-like receptors associated with immunoreceptor tyrosine-based activation motif (ITAM)-harboring adaptors. In addition to the calcineurin-NFATc1 axis, calcium signaling activates the calmodulin-dependent kinase pathway, which also plays a critical role in osteoclast formation. Such advances in the understanding of the molecular mechanism of osteoclast differentiation are expected to lead to novel therapeutic approaches to bone diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18083930     DOI: 10.1196/annals.1402.071

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  161 in total

Review 1.  Cellular communications in bone homeostasis and repair.

Authors:  Ken-Ichi Nakahama
Journal:  Cell Mol Life Sci       Date:  2010-08-08       Impact factor: 9.261

2.  Reciprocal regulation of Notch and nuclear factor of activated T-cells (NFAT) c1 transactivation in osteoblasts.

Authors:  Stefano Zanotti; Anna Smerdel-Ramoya; Ernesto Canalis
Journal:  J Biol Chem       Date:  2010-12-03       Impact factor: 5.157

Review 3.  Notch and the regulation of osteoclast differentiation and function.

Authors:  Jungeun Yu; Ernesto Canalis
Journal:  Bone       Date:  2020-06-08       Impact factor: 4.398

Review 4.  Investigating Osteocytic Perilacunar/Canalicular Remodeling.

Authors:  Cristal S Yee; Charles A Schurman; Carter R White; Tamara Alliston
Journal:  Curr Osteoporos Rep       Date:  2019-08       Impact factor: 5.096

5.  Cell Adhesion Molecule CD166 Drives Malignant Progression and Osteolytic Disease in Multiple Myeloma.

Authors:  Linlin Xu; Khalid S Mohammad; Hao Wu; Colin Crean; Bradley Poteat; Yinghua Cheng; Angelo A Cardoso; Christophe Machal; Helmut Hanenberg; Rafat Abonour; Melissa A Kacena; John Chirgwin; Attaya Suvannasankha; Edward F Srour
Journal:  Cancer Res       Date:  2016-09-07       Impact factor: 12.701

6.  Selective role of calcineurin in haematopoiesis and lymphopoiesis.

Authors:  Elena M Gallo; Lena Ho; Monte M Winslow; Tracy L Staton; Gerald R Crabtree
Journal:  EMBO Rep       Date:  2008-09-26       Impact factor: 8.807

7.  A novel T cell cytokine, secreted osteoclastogenic factor of activated T cells, induces osteoclast formation in a RANKL-independent manner.

Authors:  Leonard Rifas; M Neale Weitzmann
Journal:  Arthritis Rheum       Date:  2009-11

8.  Rosmarinic acid and arbutin suppress osteoclast differentiation by inhibiting superoxide and NFATc1 downregulation in RAW 264.7 cells.

Authors:  Akina Omori; Yoshitaka Yoshimura; Yoshiaki Deyama; Kuniaki Suzuki
Journal:  Biomed Rep       Date:  2015-04-17

9.  Specific RANK Cytoplasmic Motifs Drive Osteoclastogenesis.

Authors:  Yuyu Li; Zhenqi Shi; Joel Jules; Shenyuan Chen; Robert A Kesterson; Dongfeng Zhao; Ping Zhang; Xu Feng
Journal:  J Bone Miner Res       Date:  2019-08-02       Impact factor: 6.741

10.  Mitogen- and stress-activated protein kinase 1 activates osteoclastogenesis in vitro and affects bone destruction in vivo.

Authors:  Jeongim Ha; Hyung Joon Kim; Hao Huang; Zang Hee Lee; Hong-Hee Kim
Journal:  J Mol Med (Berl)       Date:  2013-04-26       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.